Key result
Serum 25-HCC levels in ischemic heart disease patients do not differ from normal persons.
Why the study?
Are serum vitamin D (25-HCC) levels elevated in patients with ischaemic heart disease compared to normal persons?
Cross-Sectional (n=549)
Are serum vitamin D (25-HCC) levels elevated in patients with ischaemic heart disease compared to normal persons?
Patients with ischaemic heart disease do not have elevated levels of vitamin D compared to normal individuals, challenging the hypothesis that it is a risk factor.
Answers are grounded in this paper and cite their sources.
No difference in 25-HCC levels does not support vitamin D as IHD risk factor; challenges prior hypotheses yet leaves open prospective validation.
Vitamin D has been proposed as a risk factor of ischaemic heart disease. In 12 patients with acute myocardial infarction the major circulating vitamin D metabolite, 25-hydroxy-cholecalciferol (25-HCC), did not show any fluctuations during the first 4 days after onset of symptoms. The serum 25-HCC level was then measured in 128 patients consecutively admitted because of chest pain, 53 of whom had myocardial infarction and 75 had angina pectoris. The values found did not differ from those measured in 409 normal persons. The seasonal variations of serum 25-HCC were less pronounced in heart patients than in normals, probably due to less sun exposure in the summer months. The levels of serum 25-HCC did not correlate with the concentrations of serum cholesterol, glycerides, calcium or magnesium. Low serum calcium and magnesium were observed in all patients. Serum calcium was further reduced in the course of acute myocardial infarctions while serum parathyroid hormone rose significantly. We conclude that patients with ischaemic heart disease are not ingesting or producing in their skin elevated amount of vitamin D.
No takes yet. Share an insight, caveat, or question.
Lund et al. (1978) conducted a cross-sectional in Ischaemic heart disease (n=549). Serum 25-hydroxy-cholecalciferol (25-HCC) vs. Normal persons was evaluated on Serum 25-hydroxy-cholecalciferol (25-HCC) levels. Serum 25-hydroxy-cholecalciferol levels in patients with ischaemic heart disease did not differ from those measured in normal persons.
Synapse has enriched 10 related papers. Consider them for comparative context: